What is NOWDiagnostics?
NOWDiagnostics, Inc., headquartered in Springdale, Arkansas, is at the forefront of developing advanced diagnostics. Their proprietary ADEXUSDx® product line offers a groundbreaking approach, enabling the analysis of common conditions, illnesses, and diseases using a single drop of blood. This innovative technology bypasses the need for traditional off-site laboratory processing, drastically reducing the time to receive test results from days to mere minutes. This efficiency positions NOWDiagnostics as a key player in accelerating diagnostic timelines and improving patient care.
How much funding has NOWDiagnostics raised?
NOWDiagnostics has raised a total of $33.4M across 2 funding rounds:
Debt
$10.9M
Series B
$22.5M
Debt (2016): $10.9M, investors not publicly disclosed
Series B (2024): $22.5M led by Kompass Kapital Management, DigitalDx Ventures, and Labcorp venture fund
Key Investors in NOWDiagnostics
Kompass Kapital Management
Kompass Kapital Management is a private equity group focused on investing in people and value-creating ventures across diverse industries, guided by conservative underwriting.
DigitalDx Ventures
DigitalDx Ventures specializes in investments at the intersection of artificial intelligence and healthcare, aiming to impact the market with game-changing technologies.
Labcorp venture fund
Labcorp venture fund invests in innovative solutions within the healthcare and diagnostics sector, aligning with strategic advancements in medical technology.
What's next for NOWDiagnostics?
With the recent major strategic investment, NOWDiagnostics is poised for significant expansion and further development of its innovative diagnostic platform. The substantial capital infusion, particularly the $22.5M from this Series B round, will likely fuel advancements in product research and development, enhance manufacturing capabilities, and broaden market reach. This strategic backing from prominent investors signals a strong belief in the company's trajectory and its capacity to disrupt the traditional diagnostics landscape, potentially leading to wider adoption of its rapid, blood-based testing solutions.
See full NOWDiagnostics company page
